| P2093 | author name string | Yuwei Wang | |
| | David W Grainger | |
| P2860 | cites work | RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 |
| | Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA | Q37219628 |
| | The challenge of establishing preclinical models for segmental bone defect research | Q37390968 |
| | Managing osteoporosis: challenges and strategies | Q37571202 |
| | Neurochemical and behavioral consequences of widespread gene knockdown in the adult mouse brain by using nonviral RNA interference | Q37704644 |
| | Increased expression of activating factors in large osteoclasts could explain their excessive activity in osteolytic diseases | Q40184342 |
| | Interactive effect of interleukin-6 and prostaglandin E2 on osteoclastogenesis via the OPG/RANKL/RANK system | Q40256895 |
| | Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation. | Q40505552 |
| | The a3 Isoform of the 100-kDa V-ATPase Subunit Is Highly but Differentially Expressed in Large (≥10 Nuclei) and Small (≤5 Nuclei) Osteoclasts | Q40632473 |
| | Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo | Q41753607 |
| | Rho GTPase protein expression and activation in murine monocytes/macrophages is not modulated by model biomaterial surfaces in serum-containing in vitro cultures | Q42148645 |
| | Differences in regulation of pH(i) in large (>/=10 nuclei) and small ( | Q42491980 |
| | The effect of a single dose of osteoprotegerin in postmenopausal women | Q43520860 |
| | Noninvasive delivery of small inhibitory RNA and other reagents to pulmonary alveoli in mice | Q44964483 |
| | Therapeutic silencing of an endogenous gene by siRNA cream in an arthritis model mouse | Q45885673 |
| | OPG and PTH-(1-34) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats | Q46099755 |
| | Is denosumab better than alendronate in the treatment of osteoporosis? | Q46192358 |
| | The use of calcium phosphate bone cement in fracture treatment. A meta-analysis of randomized trials | Q46332309 |
| | Identifying the relative contributions of Rac1 and Rac2 to osteoclastogenesis | Q46961300 |
| | Cell fusion in osteoclasts plays a critical role in controlling bone mass and osteoblastic activity. | Q51947476 |
| | Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1 | Q57675161 |
| | Bisphosphonates | Q61786757 |
| | Recombinant Dicer efficiently converts large dsRNAs into siRNAs suitable for gene silencing | Q73015350 |
| | Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast | Q77350563 |
| | Phenotypic non-equivalence of murine (monocyte-) macrophage cells in biomaterial and inflammatory models | Q80928315 |
| | Bone: bone density screening leads to reduced fracture risk | Q82245195 |
| | Stimulation by toll-like receptors inhibits osteoclast differentiation | Q24301850 |
| | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 |
| | Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging | Q25255924 |
| | Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans | Q27860867 |
| | The costs of using unauthenticated, over-passaged cell lines: how much more data do we need? | Q27910526 |
| | Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families | Q28137631 |
| | Denosumab: anti-RANKL antibody | Q28236159 |
| | RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis | Q28293009 |
| | TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling | Q28513445 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | Osteoclast differentiation and activation | Q29547556 |
| | Resorptive state and cell size influence intracellular pH regulation in rabbit osteoclasts cultured on collagen-hydroxyapatite films | Q31967766 |
| | Comparison of effects of the bisphosphonate alendronate versus the RANKL inhibitor denosumab on murine fracture healing. | Q33385262 |
| | Physiology and pathophysiology of bone remodeling. | Q33701893 |
| | Future challenges for drug delivery | Q33750617 |
| | Treatment of hypercalcemia of malignancy with bisphosphonates | Q33964327 |
| | The osteoblast: a sophisticated fibroblast under central surveillance | Q34021172 |
| | Osteoporosis prevention, diagnosis, and therapy | Q34140339 |
| | Insulin self-association and the relationship to pharmacokinetics and pharmacodynamics. | Q34233694 |
| | Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL. | Q34469691 |
| | RNAi therapeutics: principles, prospects and challenges | Q34621268 |
| | Management of Paget's disease of bone | Q34649589 |
| | Bisphosphonates: clinical experience | Q35905962 |
| | RNA silencing and genome regulation. | Q36113252 |
| | Gene manipulation through the use of small interfering RNA (siRNA): from in vitro to in vivo applications. | Q36792039 |
| | Dissociation between bone resorption and bone formation in osteopenic transgenic mice | Q36800774 |
| | Clinical risk factors for fracture in postmenopausal osteoporotic women: a review of the recent literature | Q37071360 |
| P433 | issue | 7 | |
| P304 | page(s) | 1273-1284 | |
| P577 | publication date | 2010-03-24 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | siRNA knock-down of RANK signaling to control osteoclast-mediated bone resorption | |
| P478 | volume | 27 | |